首页> 外文期刊>International journal of hematology >Loss of promoter methylation contributes to the expression of functionally impaired PRDM1beta isoform in diffuse large B-cell lymphoma.
【24h】

Loss of promoter methylation contributes to the expression of functionally impaired PRDM1beta isoform in diffuse large B-cell lymphoma.

机译:启动子甲基化的丧失有助于弥散性大B细胞淋巴瘤中功能受损的PRDM1beta亚型的表达。

获取原文
获取原文并翻译 | 示例
           

摘要

The positive regulatory domain I (PRDM1) is a transcriptional repressor that plays an important role in the B-cell differentiation. PRDM1beta isoform is functionally impaired and overexpressed in a subset of diffuse large B-cell lymphoma with aggressive behavior. To investigate the possible epigenetic alteration on PRDM1beta expression, methylation of PRDM1beta promoter was assessed in B-lymphoma cell lines by bisulfite-sequencing PCR and screened in tumor samples of DLBCL patients using MassARRAY-quantitative methylation analysis. PRDM1beta expression corresponded to promoter methylation status. CpG island of PRDM1beta promoter possessed significant transcriptional activity, which could be modified by methylation. Loss of promoter methylation of PRDM1beta was more frequently detected in lymphoma samples than in reactive hyperplasia. Thus, demethylation of abnormal tumor suppressor gene isoform might be linked to lymphoma progression.
机译:阳性调节域I(PRDM1)是转录阻遏物,在B细胞分化中起重要作用。 PRDM1beta亚型功能受损和过度侵袭行为的弥漫性大B细胞淋巴瘤的子集中。为了研究PRDM1beta表达的可能的表观遗传学改变,通过亚硫酸氢盐测序PCR在B淋巴瘤细胞系中评估了PRDM1beta启动子的甲基化,并使用MassARRAY定量甲基化分析筛选了DLBCL患者的肿瘤样本。 PRDM1beta表达对应于启动子甲基化状态。 PRDM1beta启动子的CpG岛具有明显的转录活性,可以被甲基化修饰。在淋巴瘤样品中比在反应性增生中更经常检测到PRDM1beta启动子甲基化的丢失。因此,异常抑癌基因同工型的去甲基化可能与淋巴瘤的进展有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号